MedElevator Войти в исследования
← Поиск публикаций

DOI 10.12932/ap-241021-1259

Медицинская библиотека · Asian Pacific journal of allergy and immunology · 2025

Real-life efficacy and drug continuation of secukinumab in treating moderate to severe plaque psoriasis in Aegean region of Turkey: a multicenter retrospective study and systematic review of the literature.

Kaçar Nida, Balcı Didem Didar, Doğan Sinan, Türkmen Meltem, Gönülal Melis, Çınar Gökhan

СтатьяСистематический обзорМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Secukinumab was demonstrated to be efficient in the treatment of moderate to severe plaque psoriasis in the phase studies. Real-life treatment experiences obtained from patients that do not meet the inclusion criteria of phase studies can provide valuable information on efficacy and safety results. Results may also differ in different ethnic populations.

OBJECTIVE

To investigate short and long-term efficacy and drug continuation of secukinumab in Turkish population.

METHODS

The study conducted in three tertiary care psoriasis centers. Patients' demographic characteristics and week 0 / 4th week / 12th week / 1st year PASI values were analyzed. For systematic review of the literature a PubMed search using the keywords "secukinumab and real and psoriasis" from inception to April 2021 was performed.

RESULTS

Mean PASI scores improved the compared to baseline at all assessment weeks (p = 0.000). In multivariate model, we found that bioexperience have negative influence on the PASI90 response at week 4. Univariate analysis showed significant relationship only between PASI90 response rate and gender at week 12 and year 1. Approximately 85% of patients remained on secukinumab treatment at the end of one year.

CONCLUSIONS

Secukinumab seems to be an effective treatment option for plaque psoriasis. According to our knowledge, this is the first study concerning about long-term efficacy and drug continuation of secukinumab from Turkey.

Для цитирования: Kaçar Nida, Balcı Didem Didar, Doğan Sinan, Türkmen Meltem, Gönülal Melis, Çınar Gökhan. Real-life efficacy and drug continuation of secukinumab in treating moderate to severe plaque psoriasis in Aegean region of Turkey: a multicenter retrospective study and systematic review of the literature.. Asian Pacific journal of allergy and immunology. 2025. DOI: 10.12932/ap-241021-1259.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.